Stryker Receives FDA Clearance for Bone Tumor Ablation System
Stryker, a medical tech company, announced its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. FDA.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
